Literature DB >> 1614223

Changes in the migratory ability of human lung and skin fibroblasts during in vitro aging and in vivo cellular senescence.

H Kondo1, Y Yonezawa.   

Abstract

The migration of human lung and skin fibroblasts was determined during in vitro aging and in vivo cellular senescence by measuring their migration from the edge of a denuded area of a monolayer. The migration of human fetal lung fibroblasts (TIG-1 and TIG-3) decreased only very slightly with increasing passage, whereas the migration of human fetal skin fibroblasts (TIG-3S) declined gradually: the difference in cell migratory ability between early and late passages was significant (P less than 0.05). The migratory patterns of skin fibroblasts from adult and elderly donors were also similar to that of fetal skin fibroblasts. Next, the migratory abilities of fibroblast lines from adult and elderly donor groups were compared, using relatively early passaged cells. The migratory ability of the elderly-donor skin fibroblast lines was significantly lower (P less than 0.05) than that of the adult-donor skin fibroblast lines. Addition of suramin and monensin suppressed the migration of fibroblasts from fetal, adult and elderly donors, which implies that fibroblast migration is regulated by growth factors and matrix substances. The relationships between the age-dependent decline of migratory ability, growth factors and the extracellular matrix are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614223     DOI: 10.1016/0047-6374(92)90001-t

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  8 in total

1.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1.

Authors:  Tsutomu Kumazaki; Sayaka Kurata; Taira Matsuo; Youji Mitsui; Tomoko Takahashi
Journal:  Hum Cell       Date:  2011-05-12       Impact factor: 4.174

3.  Inhibitory effects of human serum on human fetal skin fibroblast migration: migration-inhibitory activity and substances in serum, and its age-related changes.

Authors:  H Kondo; Y Yonezawa; H Ito
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-04       Impact factor: 2.416

4.  Autonomous migration of human fetal skin fibroblasts into a denuded area in a cell monolayer is mediated by basic fibroblast growth factor and collagen.

Authors:  H Kondo; R Matsuda; Y Yonezawa
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

5.  The effect of skeletal maturity on the regenerative function of intrinsic ACL cells.

Authors:  Ashley N Mastrangelo; Elise M Magarian; Matthew P Palmer; Patrick Vavken; Martha M Murray
Journal:  J Orthop Res       Date:  2010-05       Impact factor: 3.494

6.  Transplantation of mesenchymal stem cells from young donors delays aging in mice.

Authors:  Jinhui Shen; Yi-Ting Tsai; Nancy M Dimarco; Michael A Long; Xiankai Sun; Liping Tang
Journal:  Sci Rep       Date:  2011-08-18       Impact factor: 4.379

7.  FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates.

Authors:  S Garfinkel; X Hu; I A Prudovsky; G A McMahon; E M Kapnik; S D McDowell; T Maciag
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

8.  N- and O-glycan cell surface protein modifications associated with cellular senescence and human aging.

Authors:  Yoko Itakura; Norihiko Sasaki; Daisuke Kami; Satoshi Gojo; Akihiro Umezawa; Masashi Toyoda
Journal:  Cell Biosci       Date:  2016-02-18       Impact factor: 7.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.